| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.003 |